Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi-aventis completes BMP Sunstone acquisition creating a strong consumer healthcare platform in China
pharmabiz
Saturday, February 26, 2011 - 11:10am
tags:
Sanofi, China
China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011
Bradenton Herald, FL
Saturday, February 26, 2011 - 11:08am
tags:
China Pharma Holdings, earnings
Actos under Investigation in Texas
Lawyers and Settlements
Saturday, February 26, 2011 - 11:06am
tags:
Actos, Takeda, diabetes, legal
Warner Chilcott tops on buys
Investor's Business Daily
Saturday, February 26, 2011 - 11:04am
tags:
Warner Chilcott
Endo Pharmaceuticals Close to Resistance
Trader's Huddle
Saturday, February 26, 2011 - 11:03am
tags:
Endo
Medicis Reports Fourth Quarter and Year-End 2010 Results
Globe NewsWire
Saturday, February 26, 2011 - 10:57am
tags:
Medicis, earnings
Teva loses its potency
MSN Money
Saturday, February 26, 2011 - 10:31am
tags:
Teva Pharmaceuticals
Shire Stock Hits New 52-Week High (SHPGY)
The Street
Saturday, February 26, 2011 - 10:30am
tags:
Shire
PHARMSYNTHEZ GRANTED ORPHAN DRUG DESIGNATION FOR VIREXXA IN THE US
Pharmiweb
Saturday, February 26, 2011 - 10:28am
tags:
Virexxa, Pharmsynthez, endometrial cancer
Teva Pharmaceuticals Wants to Lift Age Restrictions on Morning After Pill
ABC News
Saturday, February 26, 2011 - 10:26am
tags:
Teva Pharmaceuticals, morning-after pill, Plan B contraceptive
12 Small-Cap Biotech Stocks Being Snapped Up by Mutual Fund Investors
Motley Fool
Saturday, February 26, 2011 - 10:21am
tags:
Achillion, Aeterna Zentaris, AVI BioPharma, Cadence Pharmaceuticals, Cambrex Corp, Obagi Medical Products, Oncolytics, Osiris Therapeutics, PharmAthene, Prolor, Rexahn, Zalicus
GeoVax loss shrinks in 2010
bizjournals.com
Saturday, February 26, 2011 - 10:18am
tags:
GeoVax Labs
Onyx Misses Q4; Gives Outlook
Yahoo/Zacks
Saturday, February 26, 2011 - 10:13am
tags:
ONYX Pharmaceuticals, earnings
FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
Yahoo/PR NewsWire
Saturday, February 26, 2011 - 10:12am
tags:
Promacta, chronic immune thrombocytopenic purpura
Lilly pays $337K penalty over pollution lawsuit
Yahoo/AP
Saturday, February 26, 2011 - 10:10am
tags:
Eli Lilly
J&J Must Defend U.S. Kickback Lawsuit Claims, Judge Rules
Bloomberg
Saturday, February 26, 2011 - 10:09am
tags:
JNJ, Risperdal, lawsuits
Why Pfizer Is Hurt by the Aurobindo Foul-Up
Seeking Alpha
Saturday, February 26, 2011 - 10:08am
tags:
Pfizer, Aurobindo, generics
Loss at HGSI Wider than Expected
Yahoo/Zacks
Saturday, February 26, 2011 - 10:05am
tags:
Human Genome Sciences, Benlysta, lupus
Sangamo shares in biotech spotlight
MarketWatch
Saturday, February 26, 2011 - 10:04am
tags:
Sangamo BioSciences, SB-728, HIV
Dividend Report Card: Bristol-Myers Squibb
Motley Fool
Saturday, February 26, 2011 - 10:03am
tags:
Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.